Physiologically Based Pharmacokinetic (PBPK) Approach to Discern Potential Population Differences in Patients with Refractory Solid Tumors and Healthy Subjects: The Effects of Fedratinib on CYP3A4 Substrate Midazolam
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS（2014）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要